Here are three things to know:
1. Clutch has been in use since receiving FDA 510(k) clearance in 2017. This expanded commercial release offers the device’s proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
2. The device’s bone opposing surfaces are enhanced with Ti-Bond technology in order to provide immediate stability and long-term fixation.
3. The device is part of Spinal Elements’ thoracolumbar portfolio.
More articles on MIS:
New case series highlights Wenzel Spine’s VariLift-LX for endoscopic TLIF: 4 things to know
5 things to know about Mazor Robotics’ Mazor X Surgical System
6 MIS spine device companies making the headlines
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
